1.0580
0.0000
(0.00%)
At close: January 31 at 8:00:44 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
8,381.0000
19,049.0000
39,850.0000
589.0000
--
Operating Expense
37,855.0000
29,612.0000
21,624.0000
23,294.0000
9,466.0000
Operating Income
-29,474.0000
-10,563.0000
18,226.0000
-22,705.0000
-9,466.0000
Net Non Operating Interest Income Expense
--
-1,328.0000
-9.0000
-2.0000
-6,847.0000
Other Income Expense
2,280.0000
1,917.0000
-14.0000
-33,986.0000
-8,307.0000
Pretax Income
-27,194.0000
-9,974.0000
18,203.0000
-56,693.0000
-24,620.0000
Tax Provision
-2.0000
12.0000
315.0000
--
--
Net Income Common Stockholders
-27,192.0000
-9,986.0000
17,888.0000
-56,693.0000
-24,620.0000
Diluted NI Available to Com Stockholders
-27,192.0000
-9,986.0000
17,888.0000
-56,693.0000
-24,620.0000
Basic EPS
-1.09
-0.46
0.90
-3.82
-5.28
Diluted EPS
-1.09
-0.46
0.87
-3.82
-5.28
Basic Average Shares
24,877.7500
21,589.8210
19,931.0800
14,852.7450
4,661.1100
Diluted Average Shares
24,877.7500
21,589.8210
20,597.2120
14,852.7450
4,661.1100
Total Operating Income as Reported
-29,474.0000
-10,563.0000
18,226.0000
-22,705.0000
-19,968.0000
Total Expenses
37,855.0000
29,612.0000
21,624.0000
23,294.0000
9,466.0000
Net Income from Continuing & Discontinued Operation
-27,192.0000
-9,986.0000
17,888.0000
-56,693.0000
-24,620.0000
Normalized Income
-27,210.9986
-10,049.2000
17,888.0000
-22,864.0000
-16,304.0000
Interest Expense
-1,328.0000
--
9.0000
2.0000
6,847.0000
Net Interest Income
--
-1,328.0000
-9.0000
-2.0000
-6,847.0000
EBIT
-28,522.0000
-9,974.0000
18,212.0000
-56,691.0000
-17,773.0000
EBITDA
-28,519.0000
-9,968.0000
18,216.0000
-56,687.0000
-17,765.0000
Reconciled Depreciation
3.0000
6.0000
4.0000
4.0000
8.0000
Net Income from Continuing Operation Net Minority Interest
-27,192.0000
-9,986.0000
17,888.0000
-56,693.0000
-24,620.0000
Total Unusual Items Excluding Goodwill
19.0000
80.0000
--
-33,829.0000
-8,316.0000
Total Unusual Items
19.0000
80.0000
--
-33,829.0000
-8,316.0000
Normalized EBITDA
-28,538.0000
-10,048.0000
18,216.0000
-22,858.0000
-9,449.0000
Tax Rate for Calcs
0.0000
0.0002
0.0000
--
--
Tax Effect of Unusual Items
0.0014
16.8000
--
--
--
12/31/2020 - 6/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LEXXW Lexaria Bioscience Corp.
0.3810
-20.62%
ENSCW Leisure Acquisition Corp.
0.0240
+4.35%
ICUCW SeaStar Medical Holding Corporation
0.0429
+24.35%
JSPRW Jasper Therapeutics, Inc.
0.1775
+42.00%
PBMWW Psyence Biomedical Ltd.
0.0197
-17.23%
CELUW Celularity Inc.
0.0699
+5.91%
TVGNW Tevogen Bio Holdings Inc.
0.0840
+12.30%
VCNX Vaccinex, Inc.
1.2500
-3.10%
SPRO Spero Therapeutics, Inc.
0.8566
-1.54%
NCNA NuCana plc
1.0200
-0.97%